Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
In a surveillance study of candidemia in cancer patients that was conducted by the European Organization for Research and Treatment of Cancer, 249 episodes were noted; Candida albicans was isolated in 70% (63) of the 90 cases involving patients with solid tumors (tumor patients) and in 36% (58) of the 159 involving those with hematologic disease (hematology patients). Neutropenia in tumor patients and acute leukemia and antifungal prophylaxis in hematology patients were significantly associated with non-albicans candidemia in a multivariate analysis. Overall 30-day mortality was 39% (97 of 249). In a univariate analysis, Candida glabrata was associated with the highest mortality rate (odds ratio, 2.66). Two multivariate analyses showed that mortality was associated with older age and severity of the underlying disease. Among hematology patients, additional factors associated with mortality were allogeneic bone marrow transplantation, septic shock, and lack of antifungal prophylaxis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also showed a significant association between receipt of antifungal prophylaxis as well as acute leukemia and a higher incidence of candidemia caused by Candida species other than C. albicans (41).”
In the citing paper
“In cancer patients, Viscoli et al. [18] also suggested that C. glabrata was associated with a higher mortality rate.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [18]
In the citing paper
“Other North American and European investigators confirmed these observations in larger hospital settings [10, 11, 13, 20, 22, 25, 26].”
From Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000 (2004) · cites this paper as [11]
In the citing paper
“Candidemia due to C. parapsilosis has increased in frequency in pediatric populations and appears to be associated with a lower mortality rate than is candidemia due to other species of Candida [110-113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
In the citing paper
“Candidemia due to C. glabrata may be associated with increased mortality in patients with cancer [113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174 · cited 1×
“However, this phenomenon has not been confirmed in large prospective studies [26-29].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 1×
“given about the patients' predisposing conditions [15].”
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679 · cited 2×
“glabrata [3, 4, 1522].”
BackgroundEpidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636 · cited 2×
“glabrata [3, 4, 1522].”
BackgroundPredominant pathogens in hospital infections
Jarvis, W. R., & Martone, W. J. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.suppl_a.19 · Cited by 578 · cited 1×
“Candida albicans accounted for about 60% of the isolated pathogens, followed by other Candida species (19%) and other fungi (21%) [1, 2].”
BackgroundImportance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542
Analysis of Binary Data (2nd ed.).
Steffey, D., Cox, D. R., & Snell, E. J. (1990) · Journal of the American Statistical Association · doi:10.2307/2289625 · Cited by 499
Komshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H., Shadduck, R. K., Rosenfeld, C. S., Ho, W. G., Islam, M. Z., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00003 · Cited by 373 · cited 1×
“However, this phenomenon has not been confirmed in large prospective studies [26-29].”
ResultWingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E., & Saral, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1847 · Cited by 340
Candida tropicalis: A Major Pathogen in Immunocompromised Patients
WINGARD, J. R., MERZ, W. G., & SARAL, R. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-4-539 · Cited by 294 · cited 1×
“albicans [30, 31], while C.”
Anaissie, E. J., Darouiche, R. O., Abi-Said, D., Uzun, O., Mera, J., Gentry, L. O., Williams, T., Kontoyiannis, D. P., Karl, C. L., & Bodey, G. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.964 · Cited by 278
Candidemia in Immunocompromised Patients
Meunier, F., Aoun, M., & Bitar, N. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.supplement_1.s120 · Cited by 174 · cited 2×
“[8] reported a 42% crude mortality rate in a”
BackgroundSelf-citationGirmenia, C., Martino, P., De Bernardis, F., Gentile, G., Boccanera, M., Monaco, M., Antonucci, G., & Cassone, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.506 · Cited by 164
Self-citationCandida infections in bone marrow transplant recipients.
Verfaillie, C. M., Weisdorf, D. J., Haake, R. J., Hostetter, M. K., Ramsay, N. K. C., & McGlave, P. B. (1991) · PubMed · Cited by 128
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals
Voss, A., Kluytmans, J. A. J. W., Koeleman, J. G. M., Spanjaard, L., Vandenbroucke-Grauls, C. M. J. E., Verbrugh, H. A., Vos, M. C., Weersink, A. Y. L., Hoogkamp-Korstanje, J. A. A., & Meis, J. F. G. M. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690507 · Cited by 128
de Repentigny, L., Phaneuf, M., & Mathieu, L. G. (1992) · Infection and Immunity · doi:10.1128/iai.60.11.4907-4914.1992 · Cited by 86
Fungemia in Patients with Leukemia
Martino, P., Girmenia, C., Micozzi, A., Raccah, R. N., Gentile, G., Venditti, M., & Mandelli, F. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199310000-00004 · Cited by 80
Self-citationCandida krusei Fungemia: Report of 4 Cases and Review of the Literature
Goldman, M., Pottage, J. C., & Weaver, D. C. (1993) · Medicine · doi:10.1097/00005792-199305000-00002 · Cited by 80
Fungemia: An increasing problem in a Danish university hospital 1989 to 1994
Bruun, B., Westh, H., & Stenderup, J. (1995) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1995.tb00456.x · Cited by 22
Breakthrough Candidemia in Neutropenic Patients
Nucci, M., Colombo, A. L., Spector, N., Velasco, E., Martins, C. A., & Pulcheri, W. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.275 · Cited by 21 · cited 1×
“were breakthrough candidemias, but only three of their patients had acute leukemia, while the others presumably had lymphoma [16].”
BackgroundFungaemia in hospitalized patients
Perduca, M., Marangoni, E., Guanziroli, A., Romero, E., & Filice, G. (1995) · Mycoses · doi:10.1111/j.1439-0507.1995.tb00069.x · Cited by 13 · cited 1×
“reports from individual centers that have witnessed a progressive increase in the rates of nosocomial candidemias, both in the global population of hospitalized patients [5-7] and in the subgroup of cancer patients [8, 9].”
Background
Cited by
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
“The most frequently implicated risk factors include the use of broad-spectrum antibacterial agents, use of central venous catheters, receipt of parenteral nutrition, receipt of renal replacement therapy by patients in ICUs, neutropenia, use of implantable prosthetic devices, and receipt of immunosuppressive agents (in…”
BackgroundPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
“The clinician must remember that yeast and fungal infections remain the primary cause of infection-associated death among patients with neutropenia or patients who undergo blood or bone marrow transplantation [200, 201].”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
“increased mortality in patients with cancer [113].”
Metadata
- Authors
- Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., De Pauw, B., Meunier, F., & the Invasive Fungal Infection Group of the EORTC
- Affiliations
- University of Genoa (IT)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05
- Volume
- 28
- Issue
- 5
- Pages
- 1071-1079
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126536749
- Cited by
- 601
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 22 · 2014: 27 · 2013: 31 · 2012: 25
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, invasive fungal infections, cancer patients, Candida albicans, non-albicans Candida, Candida glabrata, solid tumors, hematologic malignancies, acute leukemia, neutropenia, antifungal prophylaxis, allogeneic bone marrow transplantation, septic shock, 30-day mortality, risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candida albicans, Candidiasis, Child, Child, Preschool, Cross Infection, Female, Humans, Male, Middle Aged, Neoplasms, Neutropenia, Population Surveillance, Prospective Studies, Multivariate Analysis, Survival Analysis, Hematologic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.